NYSE:CNC - Centene Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $92.29
  • Forecasted Upside: 14.58 %
  • Number of Analysts: 18
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.67 (0.84%)

This chart shows the closing price for CNC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Centene Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNC

Analyst Price Target is $92.29
▲ +14.58% Upside Potential
This price target is based on 18 analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $92.29, with a high forecast of $109.00 and a low forecast of $77.00. The average price target represents a 14.58% upside from the last price of $80.55.

This chart shows the closing price for CNC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 18 polled investment analysts is to buy stock in Centene. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/11/2022Sanford C. BernsteinBoost Price Target$94.00 ➝ $108.00High
1/7/2022BarclaysInitiated CoverageOverweight ➝ Overweight$95.00Medium
1/5/2022Truist SecuritiesBoost Price TargetBuy ➝ Buy$94.00 ➝ $96.00High
1/5/2022TruistBoost Price TargetBuy ➝ Buy$94.00 ➝ $96.00High
12/17/2021Morgan StanleyBoost Price TargetOverweight$86.00 ➝ $109.00Low
12/14/2021The Goldman Sachs GroupInitiated CoverageNeutral$83.00High
12/13/2021Truist SecuritiesBoost Price TargetBuy$90.00 ➝ $94.00Low
12/13/2021TruistBoost Price TargetBuy ➝ Buy$90.00 ➝ $94.00Medium
12/13/2021Truist FinancialBoost Price TargetBuy$90.00 ➝ $94.00Low
12/13/2021Wolfe ResearchBoost Price TargetOutperform$72.00 ➝ $80.00Low
12/13/2021StephensBoost Price TargetOverweight ➝ Overweight$82.00 ➝ $102.00Low
12/13/2021Bank of AmericaBoost Price TargetBuy$85.00 ➝ $93.00Low
12/13/2021OppenheimerBoost Price TargetOutperform ➝ Outperform$90.00 ➝ $95.00Low
12/13/2021Wells Fargo & CompanyBoost Price TargetOverweight$88.00 ➝ $90.00Medium
12/13/2021Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$75.00 ➝ $86.00Medium
12/13/2021BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$93.00 ➝ $100.00Medium
12/13/2021MizuhoBoost Price TargetNeutral ➝ Neutral$70.00 ➝ $78.00Medium
11/1/2021CitigroupDowngradeBuy ➝ Neutral$77.00Medium
10/27/2021Credit Suisse GroupBoost Price TargetNeutral$70.00 ➝ $75.00High
10/27/2021Morgan StanleyBoost Price TargetOverweight$79.00 ➝ $86.00High
9/14/2021Credit Suisse GroupLower Price TargetNeutral$73.50 ➝ $70.00High
9/14/2021Morgan StanleyLower Price TargetOverweight$88.00 ➝ $79.00High
9/9/2021CowenInitiated CoverageOutperform$87.00High
9/8/2021MizuhoLower Price TargetNeutral$75.00 ➝ $67.00Medium
8/31/2021Morgan StanleyLower Price TargetOverweight$94.00 ➝ $88.00Medium
8/17/2021Roth CapitalInitiated CoverageBuyHigh
8/3/2021Wells Fargo & CompanyLower Price TargetOverweight$93.00 ➝ $88.00Low
7/9/2021Seaport Res PtnReiterated RatingBuyLow
6/17/2021CitigroupBoost Price TargetBuy ➝ Buy$80.00 ➝ $86.00Medium
6/17/2021Truist SecuritiesBoost Price TargetBuy$80.00 ➝ $90.00High
6/17/2021Wells Fargo & CompanyBoost Price TargetOverweight$87.00 ➝ $93.00High
6/17/2021OppenheimerReiterated RatingBuy$90.00High
6/17/2021BMO Capital MarketsBoost Price TargetPositive ➝ Outperform$88.00 ➝ $93.00High
6/17/2021MizuhoBoost Price TargetNeutral$65.00 ➝ $75.00High
6/8/2021Bank of AmericaBoost Price TargetBuy$75.00 ➝ $85.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00N/A
5/18/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00Low
5/11/2021BMO Capital MarketsBoost Price TargetOutperform$77.00 ➝ $88.00Medium
5/11/2021StephensUpgradeEqual Weight ➝ Overweight$71.00 ➝ $87.00Medium
4/28/2021BMO Capital MarketsLower Price Target$88.00 ➝ $77.00Medium
3/15/2021MizuhoInitiated CoverageNeutral$65.00N/A
3/9/2021MizuhoInitiated CoverageNeutral$65.00Low
1/21/2021The Goldman Sachs GroupInitiated CoverageNeutralLow
1/15/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$75.00 ➝ $72.00Medium
12/21/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$83.00 ➝ $77.00Medium
12/14/2020SVB LeerinkLower Price TargetOutperform$80.00 ➝ $75.00High
11/11/2020Piper SandlerBoost Price TargetOverweight$83.00 ➝ $89.00Medium
10/28/2020Credit Suisse GroupLower Price TargetNeutral$72.50 ➝ $67.50Medium
10/28/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$87.00 ➝ $83.00High
10/28/2020SVB LeerinkBoost Price TargetOutperform$78.00 ➝ $80.00High
9/22/2020StephensDowngradeOverweight ➝ Equal WeightMedium
9/22/2020BarclaysBoost Price TargetOverweight$72.00 ➝ $84.00High
7/29/2020Jefferies Financial GroupLower Price TargetBuy$85.00 ➝ $83.00Low
7/29/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$80.00 ➝ $87.00Medium
7/1/2020SVB LeerinkInitiated CoverageOutperform$78.00High
6/12/2020OppenheimerInitiated CoverageBuy$90.00Low
4/29/2020Bank of AmericaReiterated RatingBuy$82.00Low
4/29/2020Credit Suisse GroupReiterated RatingHold$72.50Low
4/29/2020CitigroupBoost Price TargetBuy$70.00 ➝ $81.00High
4/29/2020OppenheimerBoost Price TargetOutperform$83.00 ➝ $90.00High
4/29/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$82.00 ➝ $80.00High
4/28/2020OppenheimerReiterated RatingBuy$83.00High
4/13/2020Morgan StanleyBoost Price TargetOverweight$85.00 ➝ $89.00Low
4/13/2020SunTrust BanksBoost Price TargetBuy$85.00 ➝ $90.00High
3/27/2020Morgan StanleyBoost Price TargetOverweight$82.00 ➝ $85.00Low
3/6/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$84.00 ➝ $82.00Medium
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$68.00 ➝ $84.00High
2/7/2020The Goldman Sachs GroupInitiated CoverageBuy$80.00Low
2/5/2020CitigroupBoost Price TargetBuy$65.00 ➝ $72.00High
2/5/2020JPMorgan Chase & Co.Initiated CoverageNeutral ➝ Overweight$88.00High
2/5/2020Credit Suisse GroupBoost Price TargetNeutral$65.00 ➝ $72.50High
2/4/2020OppenheimerInitiated CoverageBuy$83.00High
2/3/2020Evercore ISIInitiated CoverageOutperform$90.00Low
1/28/2020Sanford C. BernsteinBoost Price TargetTop Pick$84.00 ➝ $103.00High
1/24/2020SunTrust BanksReiterated RatingBuy$77.00 ➝ $85.00Low
1/24/2020Wells Fargo & CompanyBoost Price TargetOverweight$72.00 ➝ $85.00High
1/8/2020Credit Suisse GroupBoost Price TargetNeutral$57.00 ➝ $65.00High
1/6/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$72.00High
12/16/2019Piper Jaffray CompaniesReiterated RatingBuy$80.00Medium
12/16/2019BMO Capital MarketsBoost Price TargetPositive ➝ Outperform$65.00 ➝ $70.00High
10/23/2019Deutsche Bank AktiengesellschaftLower Price TargetBuy$62.00 ➝ $60.00Low
10/23/2019Credit Suisse GroupLower Price TargetNeutral$63.00 ➝ $57.00High
9/26/2019Morgan StanleyLower Price TargetOverweight$64.00 ➝ $62.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$62.00High
8/23/2019Morgan StanleyLower Price TargetOverweight$71.00 ➝ $64.00Medium
7/12/2019Morgan StanleyLower Price TargetOverweight$75.00 ➝ $71.00Medium
5/10/2019CitigroupUpgradeNeutral ➝ Buy$69.00Medium
4/24/2019SunTrust BanksLower Price TargetBuy$80.00Low
4/24/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$83.00 ➝ $75.00Low
4/21/2019Cantor FitzgeraldReiterated RatingBuy$83.00Low
3/31/2019CowenReiterated RatingBuy$77.00Low
3/29/2019Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$76.00 ➝ $63.00Low
2/28/2019CowenInitiated CoverageOutperform$77.00High
2/27/2019Cantor FitzgeraldReiterated RatingBuy$83.00Medium
2/7/2019Jefferies Financial GroupReiterated RatingBuy$76.00Low
2/6/2019OppenheimerLower Price TargetOutperform$165.00 ➝ $83.00Low
1/14/2019StephensInitiated CoverageOverweight$73.50Medium
12/17/2018The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyHigh
12/17/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$72.50 ➝ $82.50High
12/13/2018Cantor FitzgeraldReiterated RatingBuy$72.50High
10/24/2018SVB LeerinkUpgradeMarket Perform ➝ Outperform$79.84High
10/2/2018OppenheimerBoost Price TargetOutperform ➝ Outperform$73.00 ➝ $79.00Low
9/19/2018Mitsubishi UFJ Financial GroupInitiated CoverageOverweight$85.00Low
9/5/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$69.00 ➝ $87.50Low
9/4/2018Credit Suisse GroupBoost Price TargetNeutral$67.00 ➝ $76.00Low
7/25/2018Piper Jaffray CompaniesReiterated RatingBuy$76.00Low
7/25/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$62.50 ➝ $67.00Low
7/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$68.00 ➝ $69.00Medium
7/25/2018Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$67.50 ➝ $72.50Medium
7/24/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$72.50 ➝ $79.00Medium
7/23/2018BarclaysInitiated CoverageOverweight$79.00Low
7/18/2018CitigroupReiterated RatingNeutral$73.50Low
7/13/2018Morgan StanleyBoost Price TargetOverweight$63.50 ➝ $68.00Low
6/18/2018OppenheimerBoost Price Target$65.00 ➝ $69.00Low
6/18/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$56.00 ➝ $62.50Medium
6/18/2018BMO Capital MarketsBoost Price TargetPositive ➝ Outperform$75.00Low
6/18/2018SVB LeerinkBoost Price TargetMarket Perform$60.00 ➝ $65.00Medium
6/18/2018Cantor FitzgeraldBoost Price TargetOverweight$68.50Medium
6/18/2018Wells Fargo & CompanyBoost Price TargetOutperform$63.00 ➝ $71.00Medium
4/25/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$63.00 ➝ $63.50Low
4/2/2018Cantor FitzgeraldReiterated RatingBuy$62.50Low
3/26/2018BMO Capital MarketsReiterated RatingBuyLow
2/13/2018SVB LeerinkReiterated RatingMarket Perform ➝ Market Perform$50.00 ➝ $45.00Low
2/7/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$55.00 ➝ $56.00Low
2/7/2018Cantor FitzgeraldBoost Price TargetBuy ➝ Overweight$57.50 ➝ $62.50Low
2/7/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$59.00 ➝ $63.00Medium
2/7/2018CitigroupReiterated RatingOutperform$61.00 ➝ $65.00Low
1/3/2018The Goldman Sachs GroupInitiated CoverageBuy$67.50Medium
12/20/2017OppenheimerBoost Price TargetOutperform$55.50 ➝ $61.00Low
12/18/2017Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$56.00 ➝ $57.50Medium
12/18/2017Piper Jaffray CompaniesReiterated RatingBuy$67.00High
12/18/2017Cantor FitzgeraldReiterated RatingBuy$57.50High
12/15/2017OppenheimerReiterated RatingBuy$55.50High
11/8/2017OppenheimerReiterated RatingBuy$55.50N/A
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$51.00N/A
10/25/2017OppenheimerBoost Price TargetOutperform$52.50 ➝ $55.50N/A
10/24/2017OppenheimerReiterated RatingBuy$52.50N/A
10/24/2017Cantor FitzgeraldReiterated RatingBuy$53.50N/A
10/24/2017CowenReiterated RatingBuy$57.50N/A
10/17/2017BMO Capital MarketsInitiated CoverageOutperform$60.00N/A
10/13/2017Jefferies Financial GroupBoost Price TargetBuy$49.00 ➝ $56.00N/A
9/29/2017OppenheimerReiterated RatingBuy$52.50Low
9/21/2017Morgan StanleyBoost Price TargetOverweight$47.00 ➝ $51.50Low
9/14/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$47.50 ➝ $55.50Low
9/13/2017SVB LeerinkReiterated RatingMarket Perform ➝ Market Perform$39.00 ➝ $45.00High
9/13/2017CowenReiterated RatingOutperform$38.50 ➝ $52.50High
9/13/2017Cantor FitzgeraldBoost Price TargetOverweight$53.50High
9/1/2017Piper Jaffray CompaniesReiterated RatingBuy$52.50Low
7/27/2017Jefferies Financial GroupReiterated RatingBuy$49.00Low
7/27/2017Piper Jaffray CompaniesReiterated RatingBuy$52.50Medium
7/26/2017CitigroupBoost Price TargetSell$40.00 ➝ $44.50Medium
7/26/2017UBS GroupReiterated RatingBuy$44.00 ➝ $47.50Low
7/26/2017Morgan StanleyReiterated RatingOverweight$43.00 ➝ $47.00Low
7/25/2017Cantor FitzgeraldReiterated RatingBuy$45.00High
7/14/2017Jefferies Financial GroupReiterated RatingBuy$47.00Low
7/14/2017Bank of AmericaBoost Price TargetBuy$46.50 ➝ $47.50Low
7/13/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$42.00 ➝ $46.00Low
7/11/2017Sanford C. BernsteinReiterated RatingOutperformMedium
6/19/2017Credit Suisse GroupReiterated RatingNeutral$39.00 ➝ $40.50Low
6/19/2017Cantor FitzgeraldReiterated RatingOverweight$44.00 ➝ $45.00Low
6/6/2017Morgan StanleyInitiated CoverageOverweight ➝ Overweight$43.00Medium
5/22/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$37.50Medium
4/29/2017Jefferies Financial GroupReiterated RatingBuy$41.50 ➝ $42.50Low
4/26/2017Evercore ISIBoost Price TargetOutperform$40.00 ➝ $41.50High
4/26/2017Stifel NicolausBoost Price TargetBuy$40.00 ➝ $42.50High
4/25/2017Cantor FitzgeraldReiterated RatingBuy$42.50 ➝ $44.00Low
4/19/2017Jefferies Financial GroupReiterated RatingBuy$39.50Medium
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$42.00Low
3/23/2017CitigroupDowngradeBuy ➝ Neutral$36.50High
3/11/2017Cantor FitzgeraldReiterated RatingOverweight$42.50N/A
2/9/2017SVB LeerinkReiterated RatingMarket Perform$31.00 ➝ $32.00N/A
2/8/2017Piper Jaffray CompaniesBoost Price TargetOverweight$33.50 ➝ $38.00N/A
2/8/2017BarclaysBoost Price TargetOverweight$37.50 ➝ $39.50N/A
2/8/2017Jefferies Financial GroupBoost Price TargetBuy$33.50 ➝ $39.50N/A
2/7/2017Cantor FitzgeraldInitiated CoverageOverweightN/A
2/6/2017Cantor FitzgeraldInitiated CoverageOverweight$42.50N/A
1/31/2017Sanford C. BernsteinUpgradeMarket Perform ➝ OutperformN/A
(Data available from 1/17/2017 forward)

News Sentiment Rating

0.43 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 3 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 15 very positive mentions
  • 20 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
  • 3 very positive mentions
  • 16 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 8 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 12 very positive mentions
  • 48 positive mentions
  • 9 negative mentions
  • 1 very negative mentions
  • 7 very positive mentions
  • 25 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
  • 10 very positive mentions
  • 23 positive mentions
  • 6 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 10 very positive mentions
  • 23 positive mentions
  • 6 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Centene logo
Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.
Read More

Today's Range

Now: $80.55
Low: $78.94
High: $80.58

50 Day Range

MA: $77.96
Low: $70.18
High: $84.72

52 Week Range

Now: $80.55
Low: $57.16
High: $85.44


3,550,082 shs

Average Volume

3,977,610 shs

Market Capitalization

$47.00 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Centene?

The following equities research analysts have issued stock ratings on Centene in the last twelve months: Bank of America Co., Barclays PLC, BMO Capital Markets, Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Roth Capital, Sanford C. Bernstein, Seaport Global Securities, Seaport Res Ptn, Stephens, The Goldman Sachs Group, Inc., TheStreet, Truist, Truist Financial Co., Truist Securities, Wells Fargo & Company, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for CNC.

What is the current price target for Centene?

17 Wall Street analysts have set twelve-month price targets for Centene in the last year. Their average twelve-month price target is $92.29, suggesting a possible upside of 14.6%. Morgan Stanley has the highest price target set, predicting CNC will reach $109.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $77.00 for Centene in the next year.
View the latest price targets for CNC.

What is the current consensus analyst rating for Centene?

Centene currently has 4 hold ratings and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CNC will outperform the market and that investors should add to their positions of Centene.
View the latest ratings for CNC.

What other companies compete with Centene?

Other companies that are similar to Centene include UnitedHealth Group, Anthem, Cigna, Humana, Molina Healthcare, Magellan Health and Triple-S Management.

How do I contact Centene's investor relations team?

Centene's physical mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company's listed phone number is (314) 725-4477 and its investor relations email address is [email protected] The official website for Centene is www.centene.com.